Temporal Trends in Survival to Adulthood Among Patients Born With Congenital Heart Disease From 1970 to 1992 in Belgium
2010/11/23 by Philip Moons, Lore Bovijn, Werner Budts +2 · 30 citations
Medicine · Biochemistry, Genetics and Molecular Biology · #Congenital Heart Disease Studies #Congenital heart defects research #Aortic Disease and Treatment Approaches
paper · doi:10.1161/circulationaha.110.946343
Abstract
BACKGROUND: Over the past decades, the life expectancy of individuals with congenital heart disease (CHD) has increased significantly. However, precise estimates for survival to adulthood are scarce for patients with CHD. We investigated the proportion of CHD patients born between 1990 and 1992 who survived into adulthood. We also compared their survival with that of CHD patients born in earlier eras and evaluated survival as a function of the type of heart defect. METHODS AND RESULTS: We reviewed the CHD program administrative and clinical database at the University Hospitals Leuven (Leuven, Belgium) and analyzed the records of 7497 CHD patients born from 1970 to 1992. Survival to 18 years of age in patients born between 1990 and 1992 was 88.6% (95% confidence interval [CI], 86.3% to 90.5%), which was significantly greater than that of patients born in previous decades (P<0.0001). For patients born between 1990 and 1992, survival into adulthood for those with mild heart defects was 98.0% (95% CI, 95.8% to 99.1%), whereas survival for those with moderate- and severe-complexity heart defects was 90.0% (95% CI, 86.8% to 92.5%) and 56.4% (95% CI, 47.4% to 64.5%), respectively. Analysis per heart defect confirmed these findings, demonstrating that patients with univentricular heart (49.1% [95% CI, 30.8% to 65.1%]) and hypoplastic left heart syndrome (7.5% [95% CI, 0.6% to 26.6%]) had the poorest survival rate. CONCLUSION: This study demonstrates that almost 90% of children with CHD have the prospect of surviving into adulthood.
Cited by
- Lifetime Prevalence of Congenital Heart Disease in the General Population From 2000 to 2010
- Pediatric Cardiac Xenotransplantation: Recommendations for the Ethical Design of Clinical Trials
- Health-Related Quality of Life in Adolescents and Young Adults with Congenital Heart Disease and Its Predictors, Including Subjective Transition Readiness to Adulthood
- Illness identity in adults with congenital heart disease: Longitudinal trajectories and associations with patient‐reported outcomes and healthcare use
- Arterial switch and neurological outcomes: A retrospective study of medical records
- Secundum atrial septal defect in adults: a practical review and recent developments. [europepmc]
- Medical factors that predict quality of life for young adults with congenital heart disease: What matters most? [europepmc]
- Better health, less spending: Redesigning the transition from pediatric to adult healthcare for youth with chronic illness. [europepmc]
- Person-centred transition programme to empower adolescents with congenital heart disease in the transition to adulthood: a study protocol for a hybrid randomised controlled trial (STEPSTONES project). [europepmc]
- Adolescents with congenital heart disease: their opinions about the preparation for transfer to adult care. [europepmc]
- Trends in Long-Term Mortality After Congenital Heart Surgery. [europepmc]
- Functional limitations and educational needs among children and adolescents with heart disease. [europepmc]
- Experiences of women with cardiac disease in pregnancy: a systematic review and metasynthesis. [europepmc]
- Atrial septal defects and pulmonary arterial hypertension. [europepmc]
- First real-world experience with mobile health telemonitoring in adult patients with congenital heart disease. [europepmc]
- Education as important predictor for successful employment in adults with congenital heart disease worldwide. [europepmc]
- Chronic intrauterine hypoxia alters neurodevelopment in fetal sheep. [europepmc]
- Global, regional, and national burden of congenital heart disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. [europepmc]
- Incidence and mortality trend of congenital heart disease at the global, regional, and national level, 1990-2017. [europepmc]
- Survival in Children With Congenital Heart Disease: Have We Reached a Peak at 97%? [europepmc]
- COVID-19 in Pediatric Patients: A Focus on CHD Patients. [europepmc]
- Antenatal and Perioperative Mechanisms of Global Neurological Injury in Congenital Heart Disease. [europepmc]
- Discontinuity of Cardiac Follow-Up in Young People With Congenital Heart Disease Transitioning to Adulthood: A Systematic Review and Meta-Analysis. [europepmc]
- Heart failure related to adult congenital heart disease: prevalence, outcome and risk factors. [europepmc]
- Disability Among Young Adults With Congenital Heart Defects: Congenital Heart Survey to Recognize Outcomes, Needs, and Well-Being 2016-2019. [europepmc]
- A Uniform Description of Perioperative Brain MRI Findings in Infants with Severe Congenital Heart Disease: Results of a European Collaboration. [europepmc]
- Last year of life of adults with congenital heart diseases: causes of death and patterns of care. [europepmc]
- A practical guideline for performing a comprehensive transthoracic echocardiogram in the congenital heart disease patient: consensus recommendations from the British Society of Echocardiography. [europepmc]
- Adults With Congenital Heart Disease: Trends in Event-Free Survival Past Middle Age. [europepmc]
- Survival From Birth Until Young Adulthood Among Individuals With Congenital Heart Defects: CH STRONG. [europepmc]
Related